STOCK TITAN

Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings date

Waters Corporation (WAT) will hold its third-quarter 2026 financial results conference call on November 3, 2026, at 8:00 a.m. Eastern Time. A live webcast will be available on Waters' Investor Relations website. The replay will remain available until at least December 1, 2026, at midnight Eastern Time.

Loading...
Loading translation...
Argus Oct 1 session
-3.15% close to close 1.2x rel. volume Open Argus
Details

News Market Reaction – WAT

On Oct 1, the day this news came out, WAT closed 3.15% below the previous close.

Data tracked by StockTitan Argus for the Oct 1 session.

Key Figures

Earnings call date and time: November 3, 2026, at 8:00 a.m. Eastern Time
Earnings call date and time
November 3, 2026, at 8:00 a.m. Eastern Time
Q3 2026 financial results conference call

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MILFORD, Mass., Oct. 1, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least December 1, 2026, at midnight Eastern Time.

About Waters Corporation 

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~15,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.

Caspar Tudor, Head of Investor Relations
investor_relations@waters.com

Cision View original content:https://www.prnewswire.com/news-releases/waters-corporation-schedules-third-quarter-2026-earnings-conference-call-302894900.html

SOURCE Waters Corporation

Keep reading